Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M20.3Revenue (TTM) $M5.0Net Margin (%)-481.4Altman Z-Score-68.0
Enterprise Value $M83.8EPS (TTM) $-1.2Operating Margin %-636.3Piotroski F-Score4
P/E(ttm)--Beneish M-Score-11.7Pre-tax Margin (%)-481.4Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.1Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %--Current Ratio0.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-95.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M21.8ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with ALXA

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ALXA is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ALXA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Grupo Ferrer Internacional, S.10% Owner 2016-06-21Buy19,465,714$0.94.44view
RINGOLD GORDONDirector 2013-09-06Buy10,000$4.77-80.29view
KING THOMAS BRAXTONPres & CEO 2013-07-26Buy40,000$4.48-79.02view
KING THOMAS BRAXTONPres & CEO 2013-07-26Buy40,000$4.48-79.02view
LANSDOWNE PARTNERS AUSTRIA GMB10% Owner 2013-01-18Sell125,000$4.75-80.21view
LANSDOWNE PARTNERS AUSTRIA GMB10% Owner 2012-12-27Buy72,189$4.85-80.62view
Cassella James VEVP, R&D and CSO 2012-12-26Sell4,558$4.9-80.82view
Simms Michael JSVP, Operations & Manuf 2012-12-26Sell4,558$4.9-80.82view
Cassella James VEVP, R&D and CSO 2012-08-27Sell10,000$4.14-77.29view
KING THOMAS BRAXTONPres & CEO 2012-08-27Sell10,000$4.14-77.29view

Quarterly/Annual Reports about ALXA:

News about ALXA:

Articles On GuruFocus.com
Wrong Marketing Lesson by Big Pharma May 03 2014 
Weekly CEO Buys Highlight: RCL, PSXP, ALXA, PAY, HAFC Aug 05 2013 
Royal Caribbean and Four Others Report $100 Thousand CEO Buys Jul 31 2013 
President and CEO of Alexza Pharmaceuticals Inc. Thomas Braxton King Bought 40,000 Shares Jul 29 2013 
Weekly CEO Buys Highlight: NYLD, ALXA, DOC, NTWK, SNV Jul 29 2013 
Alexza Pharmaceuticals Inc. (ALXA) SVP, CFO & Sec August J Moretti sells 10,000 Shares May 07 2010 
Alexza Pharmaceuticals Inc. (ALXA) SVP, CFO & Sec August J Moretti sells 14,000 Shares Dec 21 2009 
Alexza Pharmaceuticals Inc. (ALXA) Pres & CEO Thomas Braxton King sells 45,000 Shares Dec 21 2009 
Weekly CEO Buy Highlight: Winmark Corp, Alexza Pharmaceuticals Inc, Ladenburg Thalmann Financial Ser Oct 11 2009 

More From Other Websites
Delisting of Securities of Alexza Pharmaceuticals, Inc., MOKO Social Media Ltd., Hercules Offshore,... Jul 01 2016
Delisting of Securities of Alexza Pharmaceuticals, Inc. from The Nasdaq Stock Market Jul 01 2016
ALEXZA PHARMACEUTICALS INC. Financials Jun 22 2016
ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Jun 21 2016
Alexza Pharmaceuticals Acquired by Ferrer Jun 21 2016
Alexza Pharmaceuticals Acquired by Ferrer Jun 21 2016
ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Jun 16 2016
Alexza Pharmaceuticals, Inc. :ALXA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016 Jun 01 2016
INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Alexza... May 16 2016
ALEXZA PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor... May 16 2016
SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Alexza... May 13 2016
ALEXZA PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly Report May 13 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale... May 13 2016
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Alexza... May 12 2016
Alexza Reports 2016 First Quarter Financial Results May 11 2016
ALEXZA PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 11 2016
Alexza Reports 2016 First Quarter Financial Results May 11 2016
Q1 2016 Alexza Pharmaceuticals Inc Earnings Release - After Market Close May 11 2016
Why is Alexza Pharmaceuticals (ALXA) Stock Soaring Today? May 10 2016
Alexza to Cancel 2016 First Quarter Financial Results Earnings Call May 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)